Experienced in Spinocerebellar Degeneration and Corneal Dystrophy

Stefan Sacu

Vienna, AT 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Spinocerebellar Degeneration and Corneal Dystrophy
Vienna, AT 
OverviewLocationsClinical Research

Overview

Stefan Sacu practices in Vienna, Austria. Mr. Sacu is rated as an Experienced expert by MediFind in the treatment of Spinocerebellar Degeneration and Corneal Dystrophy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Vein Occlusion, Vitrectomy, and Cataract Removal.

His clinical research consists of co-authoring 130 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Spinocerebellar Degeneration and Corneal Dystrophy.

Gender
Male

Locations

Vienna, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Personalized Treatment Aided by Automated Analysis of Fluid in Active Neovascular Age-related Macular Degeneration (nAMD) in a Prospective, Multicenter, Randomized Study.
Personalized Treatment Aided by Automated Analysis of Fluid in Active Neovascular Age-related Macular Degeneration (nAMD) in a Prospective, Multicenter, Randomized Study.
Enrollment Status: Recruiting
Publish Date: November 25, 2024
Intervention Type: Drug
Study Drug: Anti-VEGF Agent
Study Phase: Phase 4
Influence of Vitrectomy and Membrane Peeling on Choroidal Thickness
Influence of Vitrectomy and Membrane Peeling on Choroidal Thickness
Enrollment Status: Completed
Publish Date: October 16, 2019
Comparison of Intravitreal Dexamethasone With Intravitreal Ranibizumab Versus Intravitreal Ranibizumab Monotherapy in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration A Prospective, Randomized, Clinical Study
Comparison of Intravitreal Dexamethasone With Intravitreal Ranibizumab Versus Intravitreal Ranibizumab Monotherapy in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration A Prospective, Randomized, Clinical Study
Enrollment Status: Completed
Publish Date: May 25, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trial

130 Total Publications

Reshaping the Burden of nAMD: National, Regional, and Global Prevalence of MNV3 and Its Correlation With Life Expectancy-The RAP Study, Report 7.
Reshaping the Burden of nAMD: National, Regional, and Global Prevalence of MNV3 and Its Correlation With Life Expectancy-The RAP Study, Report 7.
Journal: Investigative ophthalmology & visual science
Published: September 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Sacu's expertise for a condition
ConditionClose
View All 11 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile